These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3260283)

  • 1. Monoclonal anti-acetylcholine receptor antibodies as probes for human acetylcholine-receptor in myasthenia gravis.
    Vincent A; Whiting PJ; Heidenreich F; Roberts A
    J Recept Res; 1988; 8(1-4):143-59. PubMed ID: 3260283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylcholine receptor antibodies and anti-idiotypic antibodies produced in blood lymphocyte cultures from patients with myasthenia gravis.
    Lefvert AK; Sundén H; Holm G
    Scand J Immunol; 1986 Jun; 23(6):655-62. PubMed ID: 3715409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-ligand antibodies as potential autoantigens: in vitro and in vivo characteristics of anti-bungarotoxin antibodies in the idiotype network.
    Pachner AR; Itano AA; McCallum RM; Ricalton NS
    Autoimmunity; 1991; 10(2):145-52. PubMed ID: 1782327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo effects of neonatal administration of antiidiotype antibodies on experimental autoimmune myasthenia gravis.
    Verschuuren JJ; Graus YM; Van Breda Vriesman PJ; Tzartos S; De Baets MH
    Autoimmunity; 1991; 10(3):173-9. PubMed ID: 1756222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-acetylcholine receptor antibody related idiotypes in myasthenia gravis.
    Lefvert AK
    J Autoimmun; 1988 Feb; 1(1):63-72. PubMed ID: 3267109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody heterogeneity and specificity in myasthenia gravis.
    Vincent A; Whiting PJ; Schluep M; Heidenreich F; Lang B; Roberts A; Willcox N; Newsom-Davis J
    Ann N Y Acad Sci; 1987; 505():106-20. PubMed ID: 2446546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are spontaneous anti-idiotypic antibodies against anti-acetylcholine receptor antibodies present in myasthenia gravis?
    Vincent AC
    J Autoimmun; 1988 Apr; 1(2):131-42. PubMed ID: 3252806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human x human hybridomas from patients with myasthenia gravis: possible tools for idiotypic therapy for myasthenia.
    Blair DA; Mihovilovic M; Agius MA; Fairclough RH; Richman DP
    Ann N Y Acad Sci; 1987; 505():155-67. PubMed ID: 3500665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The main immunogenic region of acetylcholine receptors does not provoke the formation of antibodies of a predominant idiotype.
    Killen JA; Hochschwender SM; Lindstrom JM
    J Neuroimmunol; 1985 Aug; 9(3-4):229-41. PubMed ID: 4019748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of an antiidiotypic antibody with acetylcholine-receptor-like binding properties from myasthenia gravis patients.
    Eng H; Lefvert AK
    Ann Inst Pasteur Immunol; 1988; 139(5):569-80. PubMed ID: 3264701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetylcholine receptor antibody characteristics in myasthenia gravis. Fractionation of alpha-bungarotoxin binding site antibodies and their relationship to IgG subclass.
    Whiting PJ; Vincent A; Newsom-Davis J
    J Neuroimmunol; 1983 Aug; 5(1):1-9. PubMed ID: 6874919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Search for cross-reactive idiotypes on monoclonal and myasthenia gravis acetylcholine receptor antibodies.
    Roberts A; Lang B; Vincent A; Newsom-Davis J
    Autoimmunity; 1992; 12(1):53-60. PubMed ID: 1617105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-idiotypic antibodies to anti-acetylcholine receptor antibody: characterization by ELISA and immunoprecipitation assays.
    Pachner AR; Sourojon M; Fuchs S
    J Neuroimmunol; 1986 Sep; 12(3):205-14. PubMed ID: 3488332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naturally occurring anti-idiotypic antibodies in myasthenia gravis patients.
    Dwyer DS; Bradley RJ; Urquhart CK; Kearney JF
    Nature; 1983 Feb 17-23; 301(5901):611-4. PubMed ID: 6402708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiotypes and anti-idiotypes in experimental autoimmune myasthenia gravis.
    Souroujon MC; Fuchs S
    Ann N Y Acad Sci; 1986; 475():81-93. PubMed ID: 3491567
    [No Abstract]   [Full Text] [Related]  

  • 16. Idiotypic network connectivity and a possible cause of myasthenia gravis.
    Dwyer DS; Vakil M; Kearney JF
    J Exp Med; 1986 Oct; 164(4):1310-8. PubMed ID: 2428915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal anti-idiotopic antibodies against myasthenia-inducing anti-acetylcholine receptor monoclonal antibodies. Preponderance of nonparatope-directed antibodies affecting antigen binding.
    Agius MA; Geannopoulos CJ; Fairclough RH; Richman DP
    J Immunol; 1988 Jan; 140(1):62-8. PubMed ID: 3257231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiotypic network in myasthenia gravis demonstrated by human monoclonal B-cell lines.
    Lefvert AK; Holm G
    Scand J Immunol; 1987 Nov; 26(5):573-8. PubMed ID: 3500505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The start of an autoimmune disease: idiotypic network during early progression of myasthenia gravis.
    Lefvert AK
    Ann Inst Pasteur Immunol; 1988; 139(6):633-43. PubMed ID: 3264703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of myasthenia gravis. Acetylcholine receptor-related antigenic determinants in tumor-free thymuses and thymic epithelial tumors.
    Kirchner T; Tzartos S; Hoppe F; Schalke B; Wekerle H; Müller-Hermelink HK
    Am J Pathol; 1988 Feb; 130(2):268-80. PubMed ID: 2449082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.